Year-end report: Clear signs of favourable market trends after a challenging 2021

Significant   Other events in Q4events in Q4   · The · Enzymatica’s partner Sanofi received approval from theExtraordinary health authorities in Mexico (Cofepris) and Turkey (TITCK),General which enabled the launch of ColdZyme in these markets.Meeting on · In December, ColdZyme was approved as a “Natural HealthOctober 18, Product” by the Canadian authorities (Health Canada).2021, resolved · In December, the Patent Office in Mexico issued ato approve an preliminary ruling that it intends to grant